A detailed history of Fine Mark National Bank & Trust transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 7,075 shares of EW stock, worth $466,879. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,075
Previous 7,380 4.13%
Holding current value
$466,879
Previous $705,000 7.38%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$84.3 - $94.31 $25,711 - $28,764
-305 Reduced 4.13%
7,075 $653,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $290 - $382
-4 Reduced 0.05%
7,380 $705,000
Q4 2023

Feb 09, 2024

BUY
$61.71 - $77.76 $9,688 - $12,208
157 Added 2.17%
7,384 $563,000
Q3 2023

Nov 15, 2023

SELL
$69.28 - $93.38 $67,755 - $91,325
-978 Reduced 11.92%
7,227 $500,000
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $271,013 - $314,024
-3,329 Reduced 28.86%
8,205 $773,000
Q1 2023

May 08, 2023

SELL
$74.26 - $84.51 $349,838 - $398,126
-4,711 Reduced 29.0%
11,534 $954,000
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $21,856 - $27,980
-320 Reduced 1.93%
16,245 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $14,250 - $18,561
173 Added 1.06%
16,565 $1.37 Million
Q2 2022

Aug 09, 2022

SELL
$86.5 - $128.27 $8,563 - $12,698
-99 Reduced 0.6%
16,392 $1.56 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $43,231 - $54,416
-424 Reduced 2.51%
16,491 $1.94 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $31,272 - $38,419
294 Added 1.77%
16,915 $2.19 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $39,311 - $46,890
382 Added 2.35%
16,621 $1.88 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $5,030 - $6,285
-60 Reduced 0.37%
16,239 $1.68 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $12,510 - $14,416
-159 Reduced 0.97%
16,299 $1.36 Million
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $11,828 - $15,052
-165 Reduced 0.99%
16,458 $1.5 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $16,999 - $22,122
-253 Reduced 1.5%
16,623 $1.33 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $629,660 - $842,063
10,943 Added 184.44%
16,876 $1.17 Million
Q1 2020

May 06, 2020

BUY
$52.41 - $81.0 $9,853 - $15,228
188 Added 3.27%
5,933 $1.12 Million
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $4,803 - $5,500
67 Added 1.18%
5,745 $1.34 Million
Q3 2019

Nov 08, 2019

BUY
$61.55 - $75.43 $16,987 - $20,818
276 Added 5.11%
5,678 $416,000
Q2 2019

Aug 08, 2019

BUY
$55.74 - $64.41 $143,140 - $165,404
2,568 Added 90.61%
5,402 $998,000
Q1 2019

May 07, 2019

SELL
$47.89 - $64.05 $81,891 - $109,525
-1,710 Reduced 37.63%
2,834 $542,000
Q4 2018

Feb 07, 2019

BUY
$46.41 - $56.94 $79,918 - $98,050
1,722 Added 61.02%
4,544 $696,000
Q3 2018

Nov 02, 2018

SELL
$45.7 - $58.03 $184,262 - $233,976
-4,032 Reduced 58.83%
2,822 $491,000
Q2 2018

Aug 03, 2018

SELL
$42.45 - $51.3 $19,484 - $23,546
-459 Reduced 6.28%
6,854 $998,000
Q1 2018

Apr 26, 2018

SELL
$37.19 - $47.45 $13,834 - $17,651
-372 Reduced 4.84%
7,313 $1.02 Million
Q4 2017

Jan 30, 2018

BUY
$33.79 - $39.39 $40,514 - $47,228
1,199 Added 18.49%
7,685 $866,000
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $235,376 - $251,851
6,486
6,486 $709,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.